EAST LANSING, Mich. — Almost a third of cerebral malaria survivors developed epilepsy or other behavioral disorders in the most comprehensive study to date of the disease in African children, solidifying the link between malaria and neuropsychiatric disorders that affect hundreds of thousands of children.
The research — led by Gretchen Birbeck, an associate professor of neurology and ophthalmology in Michigan State University’s College of Osteopathic Medicine — appears in the current edition of The Lancet Neurology.
Cerebral malaria is a severe form of malaria affecting the brain, occurring predominantly in children, with a mortality rate of 15-25 percent. It affects about one million children every year, primarily in sub-Saharan Africa.
“Our findings show that children with cerebral malaria are at risk of developing several adverse neurological outcomes including epilepsy, disruptive behavior disorders and disabilities characterized by motor, sensory or language deficits,” said Birbeck, also director for the International Neurologic & Psychiatric Epidemiology Program. “Specifically, the modifiable risk factors for these disorders in children with cerebral malaria are acute seizures and extreme fevers.”
Since most of the neurologic effects did not present themselves immediately, they were not evident at the time of the child’s discharge from the hospital after the initial malaria illness.
“But if the findings of our study are generalized, then about 135,000 African children younger than 5 years develop epilepsy due to cerebral malaria-induced brain injury each year, and cerebral malaria may be one of the more common causes of epilepsy in malaria-endemic regions,” she said.
The study looked at several hundred children during a nearly five-year period in Blantyre, Malawi; it was the first-ever prospective study of cerebral malaria survivors that included a control group. The study was funded by the National Institutes of Health and the Wellcome Trust.
The impact of the findings on African society is immeasurable, Birbeck said.
“The long-term loss of human potential from these disorders is mind-boggling,” she said. “Yes, these children are surviving the malaria, but their quality of life and what they contribute to society is severely hampered. There is a huge burden of post-malaria neurological disorders.”
But Birbeck said there are steps that can be taken.
“We need to be more aggressive in treating the two major risk factors: seizures and high fever,” she said, adding that the next step will be to start clinical trials to identify treatments aimed at better seizure and fever control.
Previous studies of neurological consequences related to cerebral malaria have been limited by poor retention rates, lack of follow-up and assessments that were stopped when the results of neurological examinations were normal.
Also, cerebral malaria is challenging to diagnose definitively. However, researchers from MSU and the University of Liverpool in England previously had discovered that diagnosing malaria retinopathy — a set of abnormalities in the eye’s retina — greatly enhances the ability to diagnose cerebral malaria. Thus, as part the study published in The Lancet Neurology, Birbeck and her team only looked at children with retinopathy-positive cerebral malaria.
Terrie Taylor, an MSU University Distinguished Professor and co-author on the paper, spends six months each year battling malaria at the Queen Elizabeth Central Hospital in Blantyre, Malawi.
“The challenge now is to devise better treatments during the cerebral malaria episode in hopes of minimizing the risk of epilepsy in years to come,” she said.
Birbeck said MSU’s continued and dedicated presence in Africa is what allows such research to be done.
“The long-term relationships that have been established with ministries of health, medical schools and investigators allow us to bring our expertise to the table,” she said.
Michigan State University has been advancing knowledge and transforming lives through innovative teaching, research and outreach for more than 150 years. MSU is known internationally as a major public university with global reach and extraordinary impact. Its 17 degree-granting colleges attract scholars worldwide who are interested in combining education with practical problem solving.
3 thoughts on “Researchers link cerebral malaria to epilepsy, behavior disorders”
I’m 31, almost 32 and have been having grand mal seizures since I was about 17. Let me tell you, it sucks. I can usually tell when one is about to come. I become foggy and unable to concentrate. My hands and feet become real cold but sweaty. My stomach hurts and I feel nauseous but can’t throw up. I become extremely uncomfortable and fidgety. All of those feelings happen for about an hour or so before hand. It’s not the best experience. Even if take more medication when I feel one coming I’ll have one. —– At some point I gain consciousness after I don’t know how long with the worst headache and no memory whatsoever of what happened prior or minutes after an episode. Occasionally I’ll bite my tongue or cheek. I’ve tried almost every kind of epileptic medication and I still have breakthroughs. My long term memory is slowly deteriorating. There is nothing I can do except to spread love, pay it forward, and enjoy life while I am still able to. I am content and have accepted my future. When you notice someone having a seizure or about to have a seizure, try to put something soft under their head and stand back. Don’t hold them down. They will eventually snap out of it. that was how a friend ask me to email aishatheorginal for help , iam free now if you have lost hope now there is hope EMAIL. firstname.lastname@example.org or email@example.com for your help or call +2348148345303 there is hope now friend
great blog and really interesting things .
I was just browsing for relevant blog posts for my project research and I happened to stumble upon yours. Many thanks for the excellent info!
Comments are closed.